Dr. Lalani on Neutrophil-Lymphocyte Ratio in RCC

Aly-Khan Lalani, MD
Published: Tuesday, Sep 19, 2017



Aly-Khan Lalani, MD, genitourinary oncology fellow, Dana-Farber Cancer Institute, discusses neutrophil-lymphocyte ratio in renal cell carcinoma (RCC).

The ratio of neutrophil to lymphocytes was compared in a study of patients with RCC treated with immunotherapy.

Neutrophils reflect the inflammatory cascade in patients with cancer, says Lalani, and lymphocytes are an important antitumor agent.
 
SELECTED
LANGUAGE


Aly-Khan Lalani, MD, genitourinary oncology fellow, Dana-Farber Cancer Institute, discusses neutrophil-lymphocyte ratio in renal cell carcinoma (RCC).

The ratio of neutrophil to lymphocytes was compared in a study of patients with RCC treated with immunotherapy.

Neutrophils reflect the inflammatory cascade in patients with cancer, says Lalani, and lymphocytes are an important antitumor agent.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x